A hemostatic device

By designing a hemostatic device containing a medical defatted cotton gauze conveyor and a granular chitosan hemostatic drug, the problem of low hemostatic efficiency of penetration and blind track injuries in the battlefield is solved, rapid hemostatic and antibacterial effects are achieved, and blood loss is reduced. More risk of death.

CN113876383BActive Publication Date: 2025-01-14河南健康广济生物技术有限公司
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202010625767.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-07-01
Publication Date
2025-01-14
Estimated Expiration
2040-07-01

AI Technical Summary

Technical Problem

The existing technology has low efficiency in handling penetration and blind path injuries on the battlefield, and cannot quickly meet the treatment needs of the injured, resulting in large amounts of bleeding to death.

Method used

A hemostatic device is designed, including a conveyor, baffle, hemostatic drug and sealing components. The conveyor is made of medical degreased cotton gauze or non-toxic water-soluble membrane, and contains granular chitosan hemostatic drugs, and supports rods and trays for Insert the wound, operate the handle for easy operation, and drive the hemostatic drug to react in the wound to stop bleeding quickly.

Benefits of technology

It achieves rapid hemostasis, prevents death caused by excessive blood loss, and the hemostatic drug is antibacterial and reduces the risk of infection. The support rod and tray are easy to clean the wound, the operating handle is easy to use, and the structure is simple and easy to produce.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113876383B_ABST
    Figure CN113876383B_ABST
Patent Text Reader

Abstract

The present invention discloses a hemostatic device, which relates to the technical field of emergency medicine drugs. The hemostatic device comprises a conveyor, a baffle, a hemostatic drug and a blocking component. The conveyor is a tube body with an opening at one end. The edge of the open end of the conveyor is fixedly connected to the edge of the baffle. A drug inlet is provided on the baffle. The hemostatic drug is loaded into the conveyor through the drug inlet. The blocking component is fixedly connected to a surface of the baffle away from the conveyor. The blocking component is used to prevent the hemostatic drug from spilling out of the conveyor through the drug inlet. Blood plasma can pass through the conveyor and contact the hemostatic drug, so that bleeding can be stopped quickly.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of emergency medicine, and in particular to a hemostatic device. Background Art

[0002] Soldiers are injured and sacrificed on the battlefield mainly due to excessive blood loss, especially penetrating wounds and blind wounds caused by bullets or shrapnel, which are more serious, causing 60% of soldiers to die due to their massive bleeding; studies have shown that rapid hemostasis and rescue within 10 minutes of injury is a key factor in determining their survival. Currently, the most commonly used methods for treating penetrating wounds and blind wounds are compression hemostasis, burning hemostasis, and the use of grease and gauze to fill and stop bleeding. However, due to the limitations of wartime conditions and treatment effects, the above-mentioned hemostasis methods have low hemostasis efficiency and long hemostasis time, which are far from meeting the treatment requirements for penetrating wounds and blind wounds. Therefore, it is very necessary to develop a hemostasis device that can quickly stop bleeding from penetrating wounds and blind wounds on the battlefield. Summary of the invention

[0003] The purpose of the present invention is to provide a hemostatic device to solve the problems existing in the above-mentioned prior art and to be able to stop bleeding quickly.

[0004] To achieve the above object, the present invention provides the following solutions:

[0005] The present invention provides a hemostatic device, which includes a conveyor, a baffle, a hemostatic drug and a blocking component. The conveyor is a tube body with an opening at one end, the edge of the open end of the conveyor is fixedly connected to the edge of the baffle, a drug inlet is provided on the baffle, and the hemostatic drug is loaded into the conveyor through the drug inlet. The blocking component is fixedly connected to a surface of the baffle away from the conveyor, and the blocking component is used to prevent the hemostatic drug from spilling out of the conveyor through the drug inlet, and plasma can pass through the conveyor and contact the hemostatic drug.

[0006] Preferably, the material of the conveyor and the material of the blocking component are both medical absorbent gauze or non-toxic water-soluble film.

[0007] Preferably, the hemostatic drug is a granular chitosan hemostatic drug.

[0008] Preferably, it also includes a support rod and a tray, one end of the support rod is fixedly connected to the baffle, and the other end of the support rod is fixedly connected to the tray, the support rod and the tray are inserted into the interior of the conveyor, the surface of the tray away from the baffle contacts the bottom surface of the conveyor, and the baffle is dragged out of the wound, and the baffle can drive the support rod and the tray to pull the hemostatic drug out of the wound.

[0009] Preferably, one end of the conveyor away from the open end of the conveyor is in the shape of a hollow semi-spherical ball, and the tray is in the shape of a hollow semi-spherical ball.

[0010] Preferably, it also includes an operating handle, one end of which is fixedly connected to a surface of the baffle away from the conveyor.

[0011] Preferably, the axis of the support rod and the axis of the operating handle coincide with the axis of the conveyor.

[0012] Preferably, a weakened portion is provided on the portion of the operating handle connected to the baffle body, and the operating handle is easily broken at the weakened portion and separated from the baffle.

[0013] Preferably, the weakened portion is an annular groove.

[0014] Preferably, the drug inlet is a plurality of fan-shaped holes evenly distributed along the circumference of the conveyor.

[0015] Compared with the prior art, the present invention has achieved the following technical effects:

[0016] The present invention provides a hemostatic device, wherein the hemostatic drug is installed inside a conveyor. The wounded or the treating personnel insert the conveyor into the wound, and the plasma in the wound passes through the conveyor and contacts and reacts with the hemostatic drug, thereby quickly stopping the bleeding and preventing the wounded from dying due to excessive blood loss.

[0017] Furthermore, the material of the conveyor is medical absorbent gauze, which is inexpensive, and the plasma in the wound can pass through the medical absorbent gauze to contact and react with the hemostatic drug; the material of the conveyor is a non-toxic water-soluble film, which can be quickly dissolved in the water in the plasma, making it easier for the plasma to contact with the hemostatic drug.

[0018] Furthermore, the granular chitosan hemostatic drug not only has the function of rapid hemostasis, but also has high antibacterial properties to prevent wound infection.

[0019] Furthermore, the setting of the support rod and the tray can support the conveyor, making it easier to enter the wound. At the same time, when the wounded is undergoing formal treatment on the wound, the baffle can drive the support rod and the tray to pull the hemostatic drug out of the wound, making it easier to clean the wound.

[0020] Furthermore, one end of the conveyor principle baffle is in the shape of a hollow semi-sphere, making it easier for the conveyor to enter the wound.

[0021] Furthermore, the setting of the operating handle makes it easy for people to take the hemostatic device.

[0022] Furthermore, the axis of the support rod and the axis of the operating handle are both coincident with the axis of the conveyor, and the support rod is supported at the center of the baffle and the tray, so the supporting effect is good.

[0023] Furthermore, the provision of the weakened portion facilitates the operation of breaking the handle and separating it from the baffle, thereby facilitating further bandaging the wound with gauze.

[0024] Furthermore, the weakened portion is an annular groove, which has a simple structure and is easy to produce.

[0025] Furthermore, the medicine inlet is a plurality of fan-shaped holes evenly distributed along the circumference of the conveyor, the baffle structure is stable, the production is simple, and the feeding is easy. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0027] Figure 1 A schematic diagram of the structure of a hemostatic device provided by the present invention;

[0028] Figure 2 A schematic diagram of the structure of an upper support rod and a tray of a hemostatic device provided by the present invention;

[0029] In the figure: 1- conveyor, 2- baffle, 3- feed port, 4- support rod, 5- tray, 6- operating handle, 7- weakened part. DETAILED DESCRIPTION

[0030] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0031] The purpose of the present invention is to provide a hemostatic device to solve the problems existing in the prior art and to achieve rapid hemostasis.

[0032] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.

[0033] The present invention provides a hemostatic device, such as Figures 1-2As shown, in this embodiment, the hemostatic device includes a conveyor 1, a baffle 2, a hemostatic drug and a blocking component. The conveyor 1 is a tube body with an opening at one end. The edge of the open end of the conveyor 1 is fixedly connected to the edge of the baffle 2. The baffle 2 is provided with a drug inlet 3. The hemostatic drug is loaded into the conveyor 1 through the drug inlet 3. The blocking component is fixedly connected to the surface of the baffle 2 away from the conveyor 1. The blocking component is used to prevent the hemostatic drug from spilling out of the conveyor 1 through the drug inlet 3. The plasma can pass through the conveyor 1 and contact the hemostatic drug. The hemostatic drug is loaded inside the conveyor 1. The wounded or the treating personnel put the conveyor 1 into the conveyor 1. Inserted into the wound, the plasma in the wound contacts and reacts with the hemostatic drug through the conveyor, which can quickly stop bleeding and prevent the wounded from dying due to excessive blood loss. The length of the conveyor is (50-160) mm, preferably 150 mm, the inner diameter of the conveyor is (10-50) mm, preferably 20 mm, the thickness of the conveyor is (0.05-1) mm, preferably 0.8 mm, the baffle 2 is a circular baffle, the diameter of the baffle 2 is (10-50) mm, preferably 20 mm, and the thickness of the baffle 2 is (1-5) mm, preferably 2 mm.

[0034] In another embodiment of the present invention, the material of the conveyor 1 and the material of the sealing component are both medical absorbent gauze or non-toxic water-soluble film. The material of the conveyor 1 is medical absorbent gauze, which is inexpensive. The plasma in the wound can pass through the medical absorbent gauze and react with the hemostatic drug; the material of the conveyor 1 is a non-toxic water-soluble film, which can be quickly dissolved in the water in the plasma, facilitating the contact between the plasma and the hemostatic drug.

[0035] In another embodiment of the present invention, the hemostatic drug is a granular chitosan hemostatic drug, which not only has the function of rapid hemostasis, but also has high antibacterial properties to prevent wound infection.

[0036] In another embodiment of the present invention, it also includes a support rod 4 and a tray 5, one end of the support rod 4 is fixedly connected to the baffle 2, and the other end of the support rod 4 is fixedly connected to the tray 5, the support rod 4 and the tray 5 are inserted into the conveyor 1, the diameter of the support rod is (1~5) mm, preferably 3 mm, the surface of the tray 5 away from the baffle 2 is in contact with the bottom surface of the conveyor 1, and the baffle 2 is dragged out of the wound. The baffle 2 can drive the support rod 4 and the tray 5 to pull the hemostatic drug out of the wound. The setting of the support rod 4 and the tray 5 can support the conveyor 1, making it easier to enter the wound. At the same time, when the wounded is formally treated for the wound, the baffle 2 can drive the support rod 4 and the tray 5 to pull the hemostatic drug out of the wound, which is convenient for cleaning the wound.

[0037] In another embodiment of the present invention, the end of the conveyor 1 away from the open end of the conveyor 1 is hollow semi-spherical, the tray 5 is hollow semi-spherical, and the thickness of the tray 5 is (0.5~2) mm, preferably 1 mm, so that the conveyor 1 can enter the wound more easily.

[0038] In another embodiment of the present invention, an operating handle 6 is further included, one end of which is fixedly connected to the surface of the baffle 2 away from the conveyor 1 to facilitate the hemostatic device to be taken by people. The length of the operating handle is (50~150) mm, preferably 10 mm.

[0039] In another embodiment of the present invention, the axis of the support rod 4 and the axis of the operating handle 6 are both coincident with the axis of the conveyor 1, and the support rod 4 is supported at the center of the baffle 2 and the tray 5, with a good supporting effect.

[0040] In another embodiment of the present invention, a weakened portion 7 is provided on the portion of the operating handle 6 connected to the baffle 2. The operating handle 6 is easily broken at the weakened portion 7 and separated from the baffle. The setting of the weakened portion 7 facilitates the operating handle 6 to break and separate from the baffle 2, thereby facilitating further bandaging of the wound with gauze.

[0041] In another embodiment of the present invention, the weakened portion 7 is an annular groove, which is located (0.5-3) mm above the baffle 2, preferably 2 mm, with a groove width of (0.5-2) mm, preferably 1.5 mm, and a groove depth of (0.5-2) mm, preferably 1.5 mm. The structure is simple and easy to produce.

[0042] In another embodiment of the present invention, the drug inlet 3 is a plurality of fan-shaped holes evenly distributed along the circumference of the conveyor 1, the number of the fan-shaped holes is 4, the radius of the fan-shaped holes is (2 to 10) mm, preferably 6 mm, and the baffle 2 has a stable structure, is easy to produce, and is easy to feed.

[0043] The present invention uses specific examples to illustrate the principles and implementation methods of the present invention. The above examples are only used to help understand the method and core ideas of the present invention. At the same time, for those skilled in the art, according to the ideas of the present invention, there will be changes in the specific implementation methods and application scope. In summary, the content of this specification should not be understood as limiting the present invention.

Claims

1. A hemostatic device, characterized in that: include: A conveyor, a baffle, a hemostatic drug and a blocking component, wherein the conveyor is a tube body with an opening at one end, the materials of the conveyor and the blocking component are both medical absorbent cotton gauze or non-toxic water-soluble film, the edge of the open end of the conveyor is fixedly connected to the edge of the baffle, a drug inlet is provided on the baffle, the hemostatic drug is loaded into the conveyor through the drug inlet, the blocking component is fixedly connected to the surface of the baffle away from the conveyor, the blocking component is used to prevent the hemostatic drug from spilling out of the conveyor through the drug inlet, the conveyor is used to be inserted into the wound, and plasma can contact the hemostatic drug through the conveyor; it also includes a support rod and a tray, one end of the support rod is fixedly connected to the baffle, and the other end of the support rod is fixedly connected to the tray, the support rod and the tray are inserted into the conveyor, the surface of the tray away from the baffle contacts the bottom surface of the conveyor, the baffle is dragged out of the wound, and the baffle can drive the support rod and the tray to pull the hemostatic drug out of the wound.

2. The hemostatic device according to claim 1, characterized in that: The hemostatic drug is a granular chitosan hemostatic drug.

3. The hemostatic device according to claim 1, characterized in that: The end of the conveyor away from the opening end of the conveyor is in the shape of a hollow semi-sphere, and the tray is in the shape of a hollow semi-sphere.

4. The hemostatic device according to claim 1, characterized in that: It also includes an operating handle, one end of which is fixedly connected to a surface of the baffle away from the conveyor.

5. The hemostatic device according to claim 4, characterized in that: The axis of the support rod and the axis of the operating handle both coincide with the axis of the conveyor.

6. The hemostatic device according to claim 4, characterized in that: A weakened portion is provided on the portion of the operating handle connected to the baffle body, and the operating handle is easily broken at the weakened portion and separated from the baffle.

7. The hemostatic device according to claim 6, characterized in that: The weakened portion is an annular groove.

8. The hemostatic device according to claim 4, characterized in that: The medicine inlet is a plurality of fan-shaped holes evenly distributed along the circumference of the conveyor.

Citation Information

Patent Citations

  • Hemostatic device of recto and anal canal

    CN107307892A

  • Hemostasis device

    CN212346636U